This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Introduction: Treating Depression and Anxiety to Remission

Alan F. Schatzberg, MD

Published: October 1, 2003

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Depression and anxiety disorders are often unrecognized and untreated, despite the development of safer and more tolerable medications. More troubling, even when patients are properly diagnosed, they are frequently undertreated, prescribed doses that are too low or given treatment for too short a duration. Patients may then endure unnecessarily lengthy periods of disability and poor functioning in all aspects of life.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 5

Quick Links: Anxiety , Anxiolytics

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...